Importance of chroman ring and tyrosine phosphorylation in the subtype-specific translocation and activation of diacylglycerol kinase α by D-α-tocopherol

Genes to Cells

Volumn 10, Issue 4, 2005, Pages 311-319

  Fukunaga Takenaka, Rika ^a   Shirai, Yasuhito ^a   Yagi, Keiko ^b   Adachi, Naoko ^a   Sakai, Norio ^a,c   Merino, Ernesto ^d   Merida, Isabel ^d   Saito, Naoaki ^a  

^a KOBE UNIVERSITY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE; CALCIUM CHELATING AGENT; CHROMAN DERIVATIVE; CIGLITAZONE; DIACYLGLYCEROL KINASE; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GENISTEIN; GREEN FLUORESCENT PROTEIN; HERBIMYCIN; MUTANT PROTEIN; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TROGLITAZONE; TROLOX C; WORTMANNIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE MUTATION; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION; WILD TYPE;

ALPHA-TOCOPHEROL; ANIMALS; CELLS, CULTURED; CHROMANS; CRICETINAE; DIACYLGLYCEROL KINASE; ENZYME ACTIVATION; GREEN FLUORESCENT PROTEINS; HUMANS; ISOENZYMES; MUTATION; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; THIAZOLIDINEDIONES; TYROSINE; VITAMIN E;

EID: 15944396476     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2005.00842.x     Document Type: Article

References (38)

1. Azzi, A., Breyer, I., Feher, M., et al. (2000) Specific cellular response to α-tocopherol. J. Nutt. 130, 1649-1652.
2. Azzi, A., Ricciarelli, R. & Zingg, J.M. (2002) Non-antioxidant molecular functions of α-tocopherol (vitamin E). FEBS Lett. 519, 8-10.
3. Baldanzi, G., Mitola, S., Cutrupi, S., et al. (2004) Activation of diacylglycerol kinase a is required for VEGF-induced angiogenic signaling in vitro. Oncogene 23, 4828-4838.
4. van Blitterswijk, W.J. & Houssa, B. (2000) Properties and functions of diacylglycerol kinases. Cell. Signal. 12, 595-605.
5. Boscoboinik, D., Szewczyk, A., Hensey, C. & Azzi, A. (1991) Inhibition of cell proliferation by α-tocopherol. J. Biol. Chem. 266, 6188-6194.
6. Bunting, M., Tang, W, Zimmerman, G.A., McIntre, T.M. & Prescott, S.M. (1996) Molecular cloning and characterization of a novel human diacylglycerol kinase. J. Biol. Chem. 271, 10230-10236.
7. Craven, P.A., Davidson, C.M. & DeRubertis. F.R. (1990) Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycolipids. Diabetes 39, 667-674.
8. Craven, P.A. & DeRubertis, F.R. (1989) Protein kinase C is activated in glomeruli from streptozocin diabetic rats: possible mediation by glucose. J. Clin. Invest. 83, 1667-1675.
9. Cutrupi, S., Baldanzi, G., Gramaglia, D., et al. (2000) Src-mediated activation of (α-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. EMBO J. 19, 4614-4622.
10. Ding, L., Traer, E., McIntyre, T.M., Zimmerman, G.A. & Prescott, S.M. (1998) The cloning and characterization of a novel human diacylglycerol kinase, DGKι. J Biol. Chem. 273, 32746-32752.
11. Fujita, T., Sugiyama, Y., Taketomi, S., et al. (1983) Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy) benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Diabetes 32, 804-810.
12. Goto, K., Fukuyama, M. & Kondo, H. (1994) Cloning and expression of a cytoskeleton-associated diacylglycerol kinase that is dominantly expressed in cerebellum. Proc. Natl. Acad. Sci. USA 91, 13042-13046.
13. Goto, K. & Kondo, H. (1993) Molecular cloning and expression of a 90-kDa diacylglycerol kinase that predominantly localizes in neurons. Proc. Natl. Acad. Sci. USA 90, 7598-7602.
14. Goto, K. & Kondo, H. (1996) A 104-kDa Molecular diacylglycerol kinase containing ankyrin-like repeats localizes in the cell nucleus. Proc. Natl. Acad. Sci. USA 93, 11196-11201.
15. Goto, K., Watanabe, M., Kondo, H., Yuasa, H., Sakane, F. & Kanoh, H. (1992) Gene cloning, sequence, expression and in situ localization of 80 kDa diacylglycerol kinase specific to oligodendrocyte of rat brain. Mol. Brain Res. 16, 75-87.
16. Houssa, B., Schaap, D., van der Wal, J., et al. (1997) Cloning of novel human diacylglycerol kinase (DGKθ) containing three cysteine-rich domains, a proline-rich region, and a plecksrin homology domain with an overlapping Ras-associating domain. J. Biol. Chem. 272, 10422-10428.
17. Inoguchi, T., Battan, R. & Handler, E. (1992) Preferential elevation of protein kinase C isofrom βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. USA 89, 11059-11063.
18. Ishii, H., Jirousek, M.R., Koya, D., et al. (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKCβ inhibitor. Science 272, 728-731.
19. Kanoh, H., Yamada, K. & Sakane, F. (2002) Diacylglycerol kinases; Emerging downstream regulators in cell signaling systems. J. Biochem. 131, 629-633.
20. Keaney, J.F. Jr, Simon, D.I. & Freedman, J.E. (1999) Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J. 13, 965-975.
21. Klauck, T.M., Xu, X., Mousseau, B. & Jaken, H. (1996) Cloning and characterization of a glucocorticoid-induced diacylglycerol kinase. J. Biol. Chem. 271, 19781-19788.
22. Kogure, K., Hama, S., Manabe, S., Tokumura, A. & Fukuzawa, K. (2002) High cytoxicity of α-tocopheryl hemisuccinate to canser cells is due to failure of their antioxidative defense systems. Cancer Lett. 186, 151-156.
23. Koya, D. & King, G. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-866.
24. Koya, D., Lee, I.K., Ishii, H., Kanoh, H. & King, G.L. (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 8, 426-435.
25. Lee, I.K., Koya, D., Ishi, H., Kanoh, H. & King, G.L. (1999) D-alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG) -protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes Res. Clin. Pract. 45, 183-190.
26. Nobe, K., Sakai, Y. & Momose, K. (1998) Alternations of diacylglycerol kinase in streptozotocin-induced diabetic rats. Cell Signal. 10, 465-471.
27. Pratico, D., Tangirala, R.K., Rader, D.J., Rokach, J. & Fitzgerald, G.A. (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nature Med. 4, 1189-1192.
28. Sakane, F., Imai, S., Kai, M., Wada, I. & Kanoh, H. (1996) Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J. Biol. Chem. 271, 8394-83401.
29. Sakane, F., Yamada, K., Kanoh, H., Yokoyama, C. & Tnanabe, T. (1990) Porcine diacylglycerol kinase sequence has zinc finger and E-F hand motifs. Nature 344, 345-348.
30. Sanjuán, M.A., Jones, D.R., Izquierdo, M. & Merida, I. (2001) Role of diacylglycerol kinase α in the attenuation of receptor signaling. J. Cell Biol. 153, 207-219.
31. Sato, K., Yamamoto, H., Otsuki, T., et al. (1997) Phosphatidylinositol 4,5-bisphosphate stimulates phosphorylation of the adaptor protein Shc by c-Src. FEBS Lett. 410, 136-140.
32. Shirai, Y., Segawa, S., Kuriyama, M., Gore, K., Sakai, N. & Saito, N. (2000) Subtype-specific translocation of diacylglycerol kinase alpha and gamma and its correlation with protein kinase C. J. Biol. Chem. 275, 24760-24766.
33. Sigounas, G., Anagnostou, A. & Steiner, M. (1997) d1-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr. Cancer 28, 30-35.
34. Tang, W., Bunting, M., Zimmerman, G,A., McIntre, T.M. & Prescott, S.M. (1996) Molecular cloning of a novel human diacylglycerol kinase highly selective for arachidonate-containing substrates. J. Biol. Chem. 271, 10237-10241.
35. Topham, M.K. & Prescott, S.M. (1999) Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions. J. Biol. Chem. 274, 11447-11450.
36. Verrier, E., Wang, L., Wadham, C., et al. (2004) PPARγ agonist ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway. Circ. Res. 94 1515-1522.
37. Wang, M., Wise, S.C., Leff, T & Su, T.Z. (1999) Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma. Diabetes 482, 254-260.
38. Yoshida, K., Torii, H., Sugiyama, Y., Fujita, T. & Tanayama, S. (1984) Rat-plasma metabolites of ciglitazone, a new antidiabetic agent. Xenobiotica 14, 249-257.